Akira Ooki

22PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|Apr 16, 2026
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023.

|Dec 18, 2025
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience.

Keitaro Shimozaki, Akira Ooki, Shota Fukuoka

|Jul 21, 2025
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.

Koshiro Fukuda, Hiroki Osumi, Akira Ooki

|Apr 29, 2025
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings.

Koshiro Fukuda, Hiroki Osumi, Keitaro Shimozaki

|Apr 28, 2025
A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study.

Toru Aoyama, Akira Ooki, Koji Oba

Pageof 4

Frequent Collaborators

7 joint publications

Hiroki Osumi

5 joint publications

Kensei Yamaguchi

5 joint publications

Takeru Wakatsuki

5 joint publications

Shota Fukuoka